Conversion Ratio between Botox(®), Dysport(®), and Xeomin(®) in Clinical Practice

Botulinum neurotoxin has revolutionized the treatment of spasticity and is now administered worldwide. There are currently three leading botulinum neurotoxin type A products available in the Western Hemisphere: onabotulinum toxin-A (ONA) Botox(®), abobotulinum toxin-A (ABO), Dysport(®), and incobotu...

Descripción completa

Detalles Bibliográficos
Autor principal: Scaglione, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810210/
https://www.ncbi.nlm.nih.gov/pubmed/26959061
http://dx.doi.org/10.3390/toxins8030065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810210/
https://www.ncbi.nlm.nih.gov/pubmed/26959061
http://dx.doi.org/10.3390/toxins8030065

Ejemplares similares